Newsletter | September 7, 2021

09.07.21 -- How Does Media Selection Impact Performance Testing Of Poorly Soluble Drugs?

Industry Insights
How Does Media Selection Impact Performance Testing Of Poorly Soluble Drugs?

On September 29, Lonza Biologics will present a webinar on the design of dissolution media to support biopredictive dissolution testing, which enables the development of bioavailability-enhancing formulations for poorly soluble drugs.

Regulatory Consideration For Biotech Startups

The whirlwind of activity emerging biopharma leaders are seeing for the first time isn’t entirely uncharted territory. Several startup veterans share insight and inspiration on clinical-stage regulatory considerations.

Regulatory Services For Accelerated Development And Commercialization

The increase in breakthrough therapy designations and other allowances for expedited regulatory review has led to ever more innovative drug products being developed under shortened timelines. Learn how to navigate today’s regulatory environment, while shortening timelines to clinical trials and commercialization.

Data Science Makes For Better Lab Science

Watch this webinar to discover how technology for searching, machine learning, predictive and prescriptive analytics, and modeling and simulation can help lab operations to leverage scientific data end-to-end to make knowledge-driven decisions in real time to ultimately speed time to market. 

Most Popular News
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.